|
US6127356A
(en)
|
1993-10-15 |
2000-10-03 |
Duke University |
Oxidant scavengers
|
|
US20060270639A1
(en)
*
|
1997-06-20 |
2006-11-30 |
Daniela Salvemini |
Combinations of superoxide dismutase mimetics and nonsteroidal analgesic/anti-inflammatory drugs
|
|
US6214817B1
(en)
*
|
1997-06-20 |
2001-04-10 |
Monsanto Company |
Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity
|
|
US20050171198A1
(en)
*
|
1997-06-20 |
2005-08-04 |
Metaphore Pharmaceuticals, Inc. |
SODm therapy for treatment, prevention, inhibition and reversal of inflammatory disease
|
|
IL135949A0
(en)
|
1997-11-03 |
2001-05-20 |
Univ Duke |
Substituted porphyrins
|
|
DK1616869T3
(da)
|
1999-01-25 |
2012-05-07 |
Nat Jewish Health |
Substituerede porphyriner og deres terapeutiske anvendelse
|
|
DE60018925T2
(de)
|
1999-05-27 |
2006-04-13 |
Pharmacia Corp.(N.D.Ges.D.Staates Delaware) |
Biomaterialien, modifiziert mit superoxid-dismutase imitatoren
|
|
US20030069281A1
(en)
*
|
2000-06-14 |
2003-04-10 |
Irwin Fridovich |
Tetrapyrroles
|
|
US20020072512A1
(en)
*
|
2000-12-08 |
2002-06-13 |
Metaphore Pharmaceuticals, Inc |
Method of preventing and treating HIV-mediated central nervous system damage
|
|
DE60235955D1
(de)
*
|
2001-01-05 |
2010-05-27 |
Metaphore Pharmaceuticals Inc |
Zusammensetzungen und verfahren zur erhöhung der zytokin-aktivität und zur behandlung der hypotension assoziiert mit der verabreichung von zytokinen
|
|
EP1392328B1
(en)
|
2001-01-19 |
2009-08-12 |
National Jewish Medical and Research Center |
Medicament for protection in radiotherapy
|
|
WO2002058686A2
(en)
*
|
2001-01-26 |
2002-08-01 |
Metaphore Pharmaceuticals, Inc. |
Method of treatment of neurodegenerative disorders using pentaaza-macrocyclic ligand complexes
|
|
EP1405066B1
(en)
*
|
2001-03-02 |
2015-06-17 |
Galera Therapeutics LLC |
Chromatography of metal complexes
|
|
US20040137638A1
(en)
|
2002-03-04 |
2004-07-15 |
Slomczynska Urszula J. |
Chromatography of metal complexes
|
|
AU2002312194B8
(en)
*
|
2001-06-01 |
2008-05-15 |
Aeolus Sciences, Inc. |
Oxidant scavengers for treatment of diabetes or use in transplantation or induction of immune tolerance
|
|
CA2449631A1
(en)
*
|
2001-06-08 |
2002-12-19 |
Metaphore Pharmaceuticals, Inc. |
Libraries of conformationally constrained peptides, chiral azacrowns, and peptidomimetics and methods of making the same
|
|
CA2451602A1
(en)
*
|
2001-06-26 |
2003-01-03 |
Metaphore Pharmaceuticals, Inc. |
Combination therapy of an sodm and a corticosteroid for prevention and/or treatment of inflammatory disease
|
|
EP1450824A4
(en)
*
|
2001-11-02 |
2005-09-28 |
Elan Corp Plc |
PHARMACEUTICAL COMPOSITION
|
|
SI1463563T1
(sl)
*
|
2001-12-14 |
2009-06-30 |
Alcon Inc |
Superoksidni dizmutazni mimetiki za zdravljenje očesnih motenj in bolezni
|
|
US6933275B2
(en)
*
|
2002-05-01 |
2005-08-23 |
The Board Of Trustees Of The Leland Stanford Junior University |
Protein kinase C peptides for use in withdrawal
|
|
AU2003237500A1
(en)
*
|
2002-06-07 |
2003-12-22 |
Duke University |
Substituted porphyrins
|
|
US20030232784A1
(en)
*
|
2002-06-14 |
2003-12-18 |
Benedict James J. |
Hyaluronic acid-associated superoxide dismutase mimics and their use in the treatment of joint pain
|
|
US6984636B2
(en)
*
|
2002-08-12 |
2006-01-10 |
Medical Research Council |
Mitochondrially targeted antioxidants
|
|
CA2499994C
(en)
*
|
2002-09-23 |
2012-07-10 |
Verion, Inc. |
Abuse-resistant pharmaceutical compositions
|
|
US20060089343A1
(en)
*
|
2002-12-06 |
2006-04-27 |
Alcon, Inc. |
Superoxide dismutase mimics for the treatment of ocular disorders and diseases
|
|
MXPA05005937A
(es)
*
|
2002-12-06 |
2005-08-18 |
Alcon Inc |
Imitaciones de superoxido de dismutasa para el tratamiento de trastornos y enfermedades oculares.
|
|
KR100648618B1
(ko)
*
|
2003-11-19 |
2006-11-23 |
주식회사 웰스킨 |
활성 산소 억제제
|
|
US20070060557A1
(en)
*
|
2003-12-11 |
2007-03-15 |
Klimko Peter G |
Superoxide dismutase mimics for the treatment of optic nerve and retinal damage
|
|
WO2006069326A2
(en)
*
|
2004-12-21 |
2006-06-29 |
Metaphore Pharmaceuticals, Inc. |
Polyethylene glycolated superoxide dismutase mimetics
|
|
US8217166B2
(en)
*
|
2005-05-05 |
2012-07-10 |
Galera Therapeutics, Llc |
Polyethylene glycolated superoxide dismutase mimetics
|
|
US20120301403A1
(en)
|
2007-06-21 |
2012-11-29 |
Galera Therapeutics, Llc |
Polyethylene glycolated superoxide dismutase mimetics
|
|
KR100724586B1
(ko)
|
2005-12-09 |
2007-06-04 |
세종대학교산학협력단 |
수퍼옥사이드 디스뮤타아제 활성을 갖는 고리화합물
|
|
US9855279B2
(en)
|
2006-10-12 |
2018-01-02 |
Galera Labs, Llc |
Methods of treating oral mucositis
|
|
US8486928B2
(en)
*
|
2007-11-14 |
2013-07-16 |
Galera Therapeutics |
Super-oxide dismutase mimetics
|
|
EP2296645B1
(en)
|
2008-05-22 |
2014-11-19 |
Galera Therapeutics, LLC |
Combination antitumor therapy
|
|
US11382895B2
(en)
|
2008-05-23 |
2022-07-12 |
National Jewish Health |
Methods for treating injury associated with exposure to an alkylating species
|
|
JP6267638B2
(ja)
|
2011-09-26 |
2018-01-24 |
ガレラ・ラブス・リミテッド・ライアビリティ・カンパニーＧａｌｅｒａ Ｌａｂｓ， Ｌｌｃ |
疾患の治療方法
|
|
IL297735B2
(en)
|
2015-08-11 |
2024-08-01 |
Galera Labs Llc |
Macrocyclic ring pentase complexes with oral bioavailability
|
|
KR20230075528A
(ko)
|
2016-05-03 |
2023-05-31 |
갈레라 랩스, 엘엘씨 |
암 치료를 위한 조합 요법
|
|
EP3506907B1
(en)
|
2016-09-01 |
2023-06-07 |
Galera Labs, LLC |
Combination cancer therapy with a pentaaza macrocyclic ring complex and an ascorbate compound
|
|
CN110520107A
(zh)
|
2017-02-15 |
2019-11-29 |
加莱拉实验室有限责任公司 |
用于局部肠递送的五氮杂大环状环配合物
|
|
EP3388082A1
(en)
|
2017-04-13 |
2018-10-17 |
Galera Labs, LLC |
Combination cancer immunotherapy with pentaaza macrocyclic ring complex
|
|
IL295620B2
(en)
|
2017-04-13 |
2024-01-01 |
Galera Labs Llc |
Combination cancer immunotherapy with pentaaza macrocyclic ring complex
|
|
MX2020008028A
(es)
|
2018-01-31 |
2020-12-11 |
Galera Labs Llc |
Terapia de combinacion para cancer con complejo de anillo macrociclico de pentaaza y agente anticancer basado en platino.
|
|
US20230071463A1
(en)
*
|
2020-02-13 |
2023-03-09 |
Teva Pharmaceuticals International Gmbh |
Solid state forms of avasopasem manganese and process for preparation thereof
|
|
AU2024300676A1
(en)
*
|
2023-07-21 |
2026-01-29 |
Board Of Regents Of The University Of Texas System |
Carcinogenesis reduction with pentaaza macrocyclic ring complex
|